Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.

Al Mamari, Said; Djordjevic, Jelena; Halliday, John S; Chapman, Roger W

Al Mamari, Said; Djordjevic, Jelena; Halliday, John S; Chapman, Roger W.

Affiliation

Al Mamari S; Transitional Gastroenterology Unit, Oxford University Hospitals, Oxford, United Kingdom. saidalmammari@hotmail.com

J Hepatol ; 58(2): 329-34, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23085647

Subject(s)

Alkaline Phosphatase/blood; Bile Duct Neoplasms/epidemiology; Bile Ducts, Intrahepatic; Cholangiocarcinoma/epidemiology; Cholangitis, Sclerosing/complications; Adult; Biomarkers/blood; Cholangitis, Sclerosing/diagnosis; Cholangitis, Sclerosing/mortality; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Bile Ducts, Intrahepatic / Cholangitis, Sclerosing / Cholangiocarcinoma / Alkaline Phosphatase Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google